Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Jefferam1on Jan 14, 2017 5:07pm
123 Views
Post# 25708789

RE:RE:RE:Surprised

RE:RE:RE:SurprisedFor the record I didn't say this stock is coming crashing down to 0.12. I followed enough penny stocks that I'm saying it wouldn't be unusual for there to be a dip. We have so little volume, all it takes is for one semi larger investor to dump. As I said I wouldn't be surprised, that doesn't imply that it is inevitable. You are reading too much into what I said.
Where did I get 12c? Out of thin air, no math or anything to support it other than similar observations of other penny stocks over the decades.
That being said, I'm optimistic, I think come June/July this stock will move up, possibly way up. Unfortunately I don't see a whole lot going on till summer. 
As for my position, I'll admit I don't have a massive one, I don't have millions of shares, but I do have a reasonable chunk, way more then what you are alluding to. So before you are so quick to cast judgement, perhaps reread what I wrote. I've always been PRO antibe, I'm just also being realistic.

Bullboard Posts